Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News GSK American Depositary Shares Representing 2 Ordinary Shares GSK

Consumer Cyclical
GSK plc is a global biopharma company. The Company’s segments include Commercial Operations and Research and Development. It develops cancer medicines for patients, including ovarian cancer, endometrial cancer, and multiple myeloma. It has developed monoclonal antibodies to help treat different diseases. Its product areas include vaccines, specialty medicines, and general medicine. It is also... see more

Recent & Breaking News (NYSE:GSK)

GSK receives FDA approval for expanded indication for FluLaval® Quadrivalent (Influenza Vaccine) for infants 6 months and older

PR Newswire November 21, 2016

GSK Files Regulatory Submission in US for Once-Daily Closed Triple Combination Therapy FF/UMEC/VI for Patients with COPD

Business Wire November 21, 2016

Drug Makers Stocks Under Scanner -- Eli Lilly, Provectus Biopharma, GlaxoSmithKline, and Novartis

PR Newswire November 8, 2016

6 Big Pharma Companies Left To Report September Quarterly Figures

Benzinga.com  October 25, 2016

Fighting Addiction and Other Unmet Medical Needs with Cannabidiol

PR Newswire September 27, 2016

HC Wainwright Initiates OncoMed Pharmaceuticals With Buy Rating, $20 Target

Benzinga.com  September 22, 2016

GSK presents positive results from phase III FULFIL study of closed triple combination therapy FF/UMEC/VI versus Symbicort® Turbohaler® in COPD at ERS International Congress

Business Wire September 6, 2016

Positive Results From the COPD Salford Lung Study Published in the NEJM and Presented at European Respiratory Congress

Business Wire September 4, 2016

Drug Makers Stocks under Review -- Bristol-Myers Squibb, AstraZeneca, Eli Lilly, and GlaxoSmithKline

PR Newswire August 25, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE August 23, 2016

GEM - Cancellation Notice

UK Regulatory news services, from the LSE August 16, 2016

ViiV starts PhIII Programme for dolutegravir & 3TC

UK Regulatory news services, from the LSE August 16, 2016

Form 8.3 - William Hill Plc

UK Regulatory news services, from the LSE August 16, 2016

ViiV Healthcare Launches Phase III Programme Evaluating a Two-drug Regimen Combining Dolutegravir and Lamivudine for HIV-1 Treatment

Canada NewsWire August 16, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE August 16, 2016

Net Asset Value(s)

UK Regulatory news services, from the BW August 16, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE August 12, 2016

Director/PDMR Shareholding

UK Regulatory news services, from the LSE August 10, 2016

Share Repurchase Programme

UK Regulatory news services, from the LSE August 9, 2016

Holding(s) in Company

UK Regulatory news services, from the LSE August 9, 2016